Why the study?
What are the clinical outcomes of AF patients after a thrombo-embolic event, and does the choice of ACE inhibitor affect mortality in HFrEF?
What are the clinical outcomes of AF patients after a thrombo-embolic event, and does the choice of ACE inhibitor affect mortality in HFrEF?
Thrombo-embolic events in AF are associated with high mortality and morbidity, while different ACE inhibitors (enalapril, lisinopril, ramipril) show equivalent effectiveness in HFrEF.
No takes yet. Share an insight, caveat, or question.
Stefan Agewall (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: